|
| |
Immunicon CorporationImmunicon is developing and commercializing diagnostic and research products for rare cell analysis and molecular research, with an initial focus on cancer. Our instruments and reagents are used to capture, count and characterize rare cells including circulating tumor cells (CTCs) in cancer patients or circulating endothelial cells (CECs), which are elevated in a variety of diseases. Our goal is to be the leader in the development and commercialization of specialized cellular analysis products that deliver high clinical impact for use in human diagnostics, life science research and pharmaceutical development
| Contact Details: |
| 3401 Masons Mill Road, Suite 100 |
| Huntingdon Valley |
| Pennsylvania |
| 19006 |
| United States of America |
| Tel: | 877.822.0777 |
| Fax: | 215.830.0751 |
| Email: | info@immunicon.com |
| WWW: | www.IMMUNICON.COM/
|
|
Loading...
|
Recent Publications by Immunicon Corporation: |  |
Circulating tumor cell analysis in patients with progressive castration-resistant prostate cancer.
PURPOSE: To better direct targeted therapies to the patients with tumors... | 22nd June, 2007
| Genitourinary Oncology Service, Immunicon Corporation, Huntingdon Valley,
| Clin Cancer Res. 2007 Apr 1;13(7):2023-9.
DOI Direct Link |
Statistical considerations for enumeration of circulating tumor cells.
BACKGROUND: Circulating tumor cells (CTCs) in patients with carcinomas are... | 3rd May, 2007
| Immunicon Corporation, Huntingdon Valley, Pennsylvania, USA.
| Cytometry A. 2007 Mar;71(3):154-62.
DOI Direct Link |
Endothelial cells in peripheral blood of healthy subjects and patients with metastatic carcinomas.
BACKGROUND: A lack of standardized assays and consensus of cell definition... | 24th April, 2007
| Immunicon Corporation, 3401 Masons Mill Road, Suite 100, Huntingdon
| Cytometry A. 2007 Feb;71(2):105-13.
DOI Direct Link |
Global gene expression profiling of circulating endothelial cells in patients with metastatic carcinomas.
Increased numbers of endothelial cells are observed in peripheral blood of... | 4th May, 2006
| Immunicon Corp., Huntingdon Valley, Pennsylvania 19006, USA.
| Cancer Res. 2006 Mar 15;66(6):2918-22.
DOI Direct Link |
Expression of epithelial cell adhesion molecule in carcinoma cells present in blood and primary and metastatic tumors.
The epithelial cell adhesion molecule (EpCAM) is involved in homophilic... | 17th September, 2005
| Immunicon Corporation, Huntingdon Valley, PA 19006, USA.
| Int J Oncol. 2005 Jul;27(1):49-57.
|
→View more Immunicon Corporation research publications. |
Press Releases on Immunicon Corporation:
|
 |
| Veridex Completes Acquisition of Immunicon Corporation Assets |
1st August, 2008 |
Veridex, LLC |
RARITAN, N.J., Aug. 1 /PRNewswire/ -- Veridex, LLC announced today it has
completed its previously announced acquisition of substantially all of the
assets of Immunicon Corporation (OTC Bulletin
|
 Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 357 times since April 2007, the link to the organisation's website has been followed 70 times Recent Search Terms used to find this page: immunicon acquisition by veridex | . Search for more companies in Huntingdon Valley Search for more companies in Pennsylvania This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for Immunicon Corporation |
